Cost-effectiveness of increasing access to contraception during the Zika virus outbreak, Puerto Rico, 2016

Rui Li, Katharine B. Simmons, Jeanne Bertolli, Brenda Rivera-Garcia, Shanna Cox, Lisa Romero, Lisa M. Koonin, Miguel Valencia-Prado, Nabal Bracero, Denise J. Jamieson, Wanda Barfield, Cynthia A. Moore, Cara T. Mai, Lauren C. Korhonen, Meghan T. Frey, Janice Perez-Padilla, Ricardo Torres-Muñoz, Scott D. Grosse

Research output: Research - peer-reviewArticle

  • 4 Citations

Abstract

We modeled the potential cost-effectiveness of increasing access to contraception in Puerto Rico during a Zika virus outbreak. The intervention is projected to cost an additional $33.5 million in family planning services and is likely to be cost-saving for the healthcare system overall. It could reduce Zika virus-related costs by $65.2 million ($2.8 million from less Zika virus testing and monitoring and $62.3 million from avoided costs of Zika virus-associated microcephaly [ZAM]). The estimates are influenced by the contraception methods used, the frequency of ZAM, and the lifetime incremental cost of ZAM. Accounting for unwanted pregnancies that are prevented, irrespective of Zika virus infection, an additional $40.4 million in medical costs would be avoided through the intervention. Increasing contraceptive access for women who want to delay or avoid pregnancy in Puerto Rico during a Zika virus outbreak can substantially reduce the number of cases of ZAM and healthcare costs.

LanguageEnglish (US)
Pages74-82
Number of pages9
JournalEmerging Infectious Diseases
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Puerto Rico
Contraception
Cost-Benefit Analysis
Disease Outbreaks
Zika Virus
Costs and Cost Analysis
Microcephaly
Unwanted Pregnancies
Family Planning Services
Contraceptive Agents
Health Care Costs
Delivery of Health Care
Pregnancy
Zika Virus Infection

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Cost-effectiveness of increasing access to contraception during the Zika virus outbreak, Puerto Rico, 2016. / Li, Rui; Simmons, Katharine B.; Bertolli, Jeanne; Rivera-Garcia, Brenda; Cox, Shanna; Romero, Lisa; Koonin, Lisa M.; Valencia-Prado, Miguel; Bracero, Nabal; Jamieson, Denise J.; Barfield, Wanda; Moore, Cynthia A.; Mai, Cara T.; Korhonen, Lauren C.; Frey, Meghan T.; Perez-Padilla, Janice; Torres-Muñoz, Ricardo; Grosse, Scott D.

In: Emerging Infectious Diseases, Vol. 23, No. 1, 01.01.2017, p. 74-82.

Research output: Research - peer-reviewArticle

Li, R, Simmons, KB, Bertolli, J, Rivera-Garcia, B, Cox, S, Romero, L, Koonin, LM, Valencia-Prado, M, Bracero, N, Jamieson, DJ, Barfield, W, Moore, CA, Mai, CT, Korhonen, LC, Frey, MT, Perez-Padilla, J, Torres-Muñoz, R & Grosse, SD 2017, 'Cost-effectiveness of increasing access to contraception during the Zika virus outbreak, Puerto Rico, 2016' Emerging Infectious Diseases, vol 23, no. 1, pp. 74-82. DOI: 10.3201/eid2301.161322
Li, Rui ; Simmons, Katharine B. ; Bertolli, Jeanne ; Rivera-Garcia, Brenda ; Cox, Shanna ; Romero, Lisa ; Koonin, Lisa M. ; Valencia-Prado, Miguel ; Bracero, Nabal ; Jamieson, Denise J. ; Barfield, Wanda ; Moore, Cynthia A. ; Mai, Cara T. ; Korhonen, Lauren C. ; Frey, Meghan T. ; Perez-Padilla, Janice ; Torres-Muñoz, Ricardo ; Grosse, Scott D./ Cost-effectiveness of increasing access to contraception during the Zika virus outbreak, Puerto Rico, 2016. In: Emerging Infectious Diseases. 2017 ; Vol. 23, No. 1. pp. 74-82
@article{a9000d76da54466484b4919563c7f93d,
title = "Cost-effectiveness of increasing access to contraception during the Zika virus outbreak, Puerto Rico, 2016",
abstract = "We modeled the potential cost-effectiveness of increasing access to contraception in Puerto Rico during a Zika virus outbreak. The intervention is projected to cost an additional $33.5 million in family planning services and is likely to be cost-saving for the healthcare system overall. It could reduce Zika virus-related costs by $65.2 million ($2.8 million from less Zika virus testing and monitoring and $62.3 million from avoided costs of Zika virus-associated microcephaly [ZAM]). The estimates are influenced by the contraception methods used, the frequency of ZAM, and the lifetime incremental cost of ZAM. Accounting for unwanted pregnancies that are prevented, irrespective of Zika virus infection, an additional $40.4 million in medical costs would be avoided through the intervention. Increasing contraceptive access for women who want to delay or avoid pregnancy in Puerto Rico during a Zika virus outbreak can substantially reduce the number of cases of ZAM and healthcare costs.",
author = "Rui Li and Simmons, {Katharine B.} and Jeanne Bertolli and Brenda Rivera-Garcia and Shanna Cox and Lisa Romero and Koonin, {Lisa M.} and Miguel Valencia-Prado and Nabal Bracero and Jamieson, {Denise J.} and Wanda Barfield and Moore, {Cynthia A.} and Mai, {Cara T.} and Korhonen, {Lauren C.} and Frey, {Meghan T.} and Janice Perez-Padilla and Ricardo Torres-Muñoz and Grosse, {Scott D.}",
year = "2017",
month = "1",
doi = "10.3201/eid2301.161322",
volume = "23",
pages = "74--82",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "1",

}

TY - JOUR

T1 - Cost-effectiveness of increasing access to contraception during the Zika virus outbreak, Puerto Rico, 2016

AU - Li,Rui

AU - Simmons,Katharine B.

AU - Bertolli,Jeanne

AU - Rivera-Garcia,Brenda

AU - Cox,Shanna

AU - Romero,Lisa

AU - Koonin,Lisa M.

AU - Valencia-Prado,Miguel

AU - Bracero,Nabal

AU - Jamieson,Denise J.

AU - Barfield,Wanda

AU - Moore,Cynthia A.

AU - Mai,Cara T.

AU - Korhonen,Lauren C.

AU - Frey,Meghan T.

AU - Perez-Padilla,Janice

AU - Torres-Muñoz,Ricardo

AU - Grosse,Scott D.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - We modeled the potential cost-effectiveness of increasing access to contraception in Puerto Rico during a Zika virus outbreak. The intervention is projected to cost an additional $33.5 million in family planning services and is likely to be cost-saving for the healthcare system overall. It could reduce Zika virus-related costs by $65.2 million ($2.8 million from less Zika virus testing and monitoring and $62.3 million from avoided costs of Zika virus-associated microcephaly [ZAM]). The estimates are influenced by the contraception methods used, the frequency of ZAM, and the lifetime incremental cost of ZAM. Accounting for unwanted pregnancies that are prevented, irrespective of Zika virus infection, an additional $40.4 million in medical costs would be avoided through the intervention. Increasing contraceptive access for women who want to delay or avoid pregnancy in Puerto Rico during a Zika virus outbreak can substantially reduce the number of cases of ZAM and healthcare costs.

AB - We modeled the potential cost-effectiveness of increasing access to contraception in Puerto Rico during a Zika virus outbreak. The intervention is projected to cost an additional $33.5 million in family planning services and is likely to be cost-saving for the healthcare system overall. It could reduce Zika virus-related costs by $65.2 million ($2.8 million from less Zika virus testing and monitoring and $62.3 million from avoided costs of Zika virus-associated microcephaly [ZAM]). The estimates are influenced by the contraception methods used, the frequency of ZAM, and the lifetime incremental cost of ZAM. Accounting for unwanted pregnancies that are prevented, irrespective of Zika virus infection, an additional $40.4 million in medical costs would be avoided through the intervention. Increasing contraceptive access for women who want to delay or avoid pregnancy in Puerto Rico during a Zika virus outbreak can substantially reduce the number of cases of ZAM and healthcare costs.

UR - http://www.scopus.com/inward/record.url?scp=85006345752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006345752&partnerID=8YFLogxK

U2 - 10.3201/eid2301.161322

DO - 10.3201/eid2301.161322

M3 - Article

VL - 23

SP - 74

EP - 82

JO - Emerging Infectious Diseases

T2 - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 1

ER -